These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26951828)

  • 1. Letter by Jogia and Liang Regarding Article, "Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate".
    Jogia D; Liang M
    Circulation; 2016 Mar; 133(10):e430. PubMed ID: 26951828
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Letter Regarding Article, "Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate".
    Goldberger JJ; Arora R; Green D; Greenland P; Lee DC; Lloyd-Jones DM; Markl M; Ng J; Shah SJ
    Circulation; 2016 Mar; 133(10):e431. PubMed ID: 26951829
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.
    Goldberger JJ; Arora R; Green D; Greenland P; Lee DC; Lloyd-Jones DM; Markl M; Ng J; Shah SJ
    Circulation; 2015 Jul; 132(4):278-91. PubMed ID: 26216085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial amyloidosis and atrial fibrillation: a gender-dependent "arrhythmogenic substrate"?
    Goette A; Röcken C
    Eur Heart J; 2004 Jul; 25(14):1185-6. PubMed ID: 15246635
    [No Abstract]   [Full Text] [Related]  

  • 5. Does Left Atrial Mechanical Dysfunction Contribute to a Thrombogenic Atrial Myopathy?
    Kamel H
    JACC Cardiovasc Imaging; 2019 Dec; 12(12):2428-2430. PubMed ID: 31005527
    [No Abstract]   [Full Text] [Related]  

  • 6. [Atrial cardiomyopathy as a link between atrial fibrillation and stroke. Clinical implications and future diagnostic-therapeutic implications].
    Mantovani F; D'Andrea A; Rizzo M; Gimelli A; Di Giannuario G; Khoury G; Pergola V; Polizzi V; Rabia G; Campana M;
    G Ital Cardiol (Rome); 2023 May; 24(5):355-364. PubMed ID: 37102348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial myopathy: A primary substrate for atrial fibrillation.
    Roberts JD; Gollob MH
    Heart Rhythm; 2022 Mar; 19(3):476-477. PubMed ID: 34906724
    [No Abstract]   [Full Text] [Related]  

  • 8. [The atrial fibrillation substrate: pulmonary veins, posterior wall or both].
    Atienza Fernández F
    Rev Esp Cardiol; 2006 Jul; 59(7):643-6. PubMed ID: 16938204
    [No Abstract]   [Full Text] [Related]  

  • 9. The atria: from morphology to function.
    Corradi D; Maestri R; Macchi E; Callegari S
    J Cardiovasc Electrophysiol; 2011 Feb; 22(2):223-35. PubMed ID: 20812935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligament and vein of Marshall: A therapeutic opportunity in atrial fibrillation.
    Rodríguez-Mañero M; Schurmann P; Valderrábano M
    Heart Rhythm; 2016 Feb; 13(2):593-601. PubMed ID: 26576705
    [No Abstract]   [Full Text] [Related]  

  • 11. Markers of collagen synthesis, atrial fibrosis, and the mechanisms underlying atrial fibrillation.
    Kalman JM; Kumar S; Sanders P
    J Am Coll Cardiol; 2012 Oct; 60(18):1807-8. PubMed ID: 23040578
    [No Abstract]   [Full Text] [Related]  

  • 12. Current concepts in the pathogenesis of atrial fibrillation.
    Kourliouros A; Savelieva I; Kiotsekoglou A; Jahangiri M; Camm J
    Am Heart J; 2009 Feb; 157(2):243-52. PubMed ID: 19185630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered atrial conduction in postoperative atrial fibrillation.
    Tokatli A; Yiginer O
    Int J Cardiol; 2016 Jan; 203():945-6. PubMed ID: 26618258
    [No Abstract]   [Full Text] [Related]  

  • 14. G-protein signaling and arrhythmogenic atrial remodeling: relevance to novel therapeutic targets in atrial fibrillation.
    Nattel S
    Heart Rhythm; 2009 Jan; 6(1):85-6. PubMed ID: 19121806
    [No Abstract]   [Full Text] [Related]  

  • 15. Atrial fibrillation in coronary artery disease: role of atrial enlargement and ischaemia.
    Wang L
    Int J Cardiol; 2000 Sep; 75(2-3):309-10. PubMed ID: 11186969
    [No Abstract]   [Full Text] [Related]  

  • 16. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.
    Burstein B; Nattel S
    J Am Coll Cardiol; 2008 Feb; 51(8):802-9. PubMed ID: 18294563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation and atrial fibrosis.
    Tan AY; Zimetbaum P
    J Cardiovasc Pharmacol; 2011 Jun; 57(6):625-9. PubMed ID: 21633248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial size and function after catheter ablation of atrial fibrillation: comparing apples and oranges.
    Hof IE; Loh P
    Am J Cardiol; 2011 Jan; 107(1):143; author reply 143-4. PubMed ID: 21146702
    [No Abstract]   [Full Text] [Related]  

  • 19. Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive Rats.
    Hohl M; Lau DH; Müller A; Elliott AD; Linz B; Mahajan R; Hendriks JML; Böhm M; Schotten U; Sanders P; Linz D
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28919580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel upstream approaches to prevent atrial fibrillation perpetuation.
    Jalife J
    Cardiol Clin; 2014 Nov; 32(4):637-50. PubMed ID: 25443242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.